维普中文期刊产品整合服务
15篇 您的检索式:作者名="Langslet"
    题名 作者 年代 出处 被引量
1Evoloeumab (AMG 145) for primary hypercholesterolemia显示文摘Langslet G Emery M Wasserman SM 2015Expert Rev Car- diovasc Ther2015,13,5:1
2ODYSSEY FH I and FH II :78 week results with a1irocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia显示文摘Kastelein JJ Ginsberg HN Langslet G 2015Eur Heart J2015,36,43:1
3Evolocumab (AMG145) for primary hypercholesterolemia 显示文摘Langslet G Emery M Wasserman SM 2015Expert Rev Car-diovasc Ther2015,13,5:1
4Cemented versus uncement- ed hemiarthroplasty for displaced femoral neck fractures: 5-year fol- lowup of a randomized trial 显示文摘Langslet E Frihagen F Opland V 2014Clin Orthop Relat Res2014,472,4:1
5Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolaemia(heFH)not adequately controlled with current lipidlowering therapy:results of ODYSSEY FHⅠand FHⅡstudies显示文摘KASTELEIN J J GINSBERG H N LANGSLET G 2015Eur Heart J2015,36,:1
6PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial显示文摘Frederick J Raal Evan A Stein Robert Dufour Traci Turner Fernando Civeira Lesley Burgess Gisle Langslet Russell Scott Anders G Olsson David Sullivan G Kees Hovingh Bertrand Cariou Ioanna Gouni-Berthold Ransi Somaratne Ian Bridges Rob Scott Scott M Wasserm 2015The Lancet . 2015 (9965)2015,,9965:1
7Cemented versus unce- mented hemiarthroplasty for displaced femoral neck fractures; 5- year followup of a randomized trial显示文摘Langslet E Frihagen F Opland V 2014Clin Orthop Relat Res2014,472,:1
8Evolocumab(AMG145)for primary hypercholesterolemia显示文摘Langslet G Emery M Wasserman SM 2015Expert Rev Cardiovasc Ther2015,5,13:1
9Reduction in lipoprotein (a) with the PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of over 1300 patients in 4 phase 2 trials显示文摘Frederick J. Raal Robert P. Giugliano Marc S. Sabatine Michael J. Koren Gisle Langslet Harold Bays Dirk Blom Mats Eriksson Ricardo Dent Scott M. Wasserman Fannie Huang Allen Xue Moetaz Albizem Rob Scott Evan A. Stein 2014Journal of the American College of Cardiology2014,,:1
10Can cardiovascular events be prevented by raising HDL cholesterol显示文摘 Reikvam A 2008Tidsskr Nor Laegforen2008,128,13:1
11Cemented versus uncemented hemiarthreplasty for displaced femoral neck fractures : 5 - year followup of a randomized trial 显示文摘Langslet E Frihagen F Opland V 2014ClirL Orthop Relat Res2014,472,4:1
12Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment显示文摘Kirsten B. Holven Ingunn Narverud Henriette W. Lindvig Bente Halvorsen Gisle Langslet Marit S. Nenseter Stine M. Ulven Leiv Ose P?l Aukrust Kjetil Retterst?l 2014Atherosclerosis2014,,:1
13Cemented versus uneemented hemiar- throplasty for displaced femoral neck fractures :5 -year followup of a ran- domized trial显示文摘Langslet E Frihagen F Opland V 2014Clin Orthop Relat Res2014,472,4:1
14Evolocumab(AMG 145)for primary hypercholesterolemia显示文摘Langslet G Emery M Wasserman S M 2015Expert Rev Cardiovasc Ther2015,13,5:1
15Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures:5-year followup of a randomized trial显示文摘Langslet E Frihagen F Opland V 2014Clin Orthop Relat Res2014,472,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费